• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

U.S. approved a vaccine against four strains of influenza

Tonka

Well-known member
http://feeds.univision.com/feeds/article/2012-02-29/eeuu-aprueba-una-vacuna-contra
Spanish-English translation


U.S. approved a vaccine against four strains of influenza

EFE | Date: 02/29/2012

Washington, Feb. 29 (EFE). - The Food and Drug Administration (FDA, for its acronym in English) today announced the approval of a vaccine that protects against four common strains of influenza, reducing the impact of the disease.

The quadrivalent FluMist will protect people from 2 to 49 years against two branches of influenza A and two influenza type B.

Vaccines containing inactivated viruses just above two types of influenza A and influenza B a, so that the sum of a new type B, increases significantly the protection.

The vaccine is administered nasally and to greater protection to influenza type B will particularly benefit children and school age groups, the FDA said.

Between 1976 and 2007, annual deaths related to influenza in the United States have ranged from a low of 3,000 to the maximum of 49,000 deaths. EFE
 
Back
Top Bottom